Drug companies investigated by Senate for fueling opioid crisis

March 28, 2017 Julie Miller

Julie Miller, Editor in Chief

A Senate committee is on task to find out whether pharmaceutical manufacturers are to blame for driving opioid prescribing practices that ultimately led to today’s addiction crisis.

Previous Article
Fixing the psychiatrist shortage requires multifaceted solution

Julie Miller, Editor in ChiefIt’s ironic that as demand grows for psychiatry services, the supply of provid...

Next Article
National Council adds new leadership

Julie Miller, Editor in ChiefThe National Council for Behavioral Health will introduce its first medical di...

×

Have Behavioral Health Business updates sent to your inbox today!

First Name
Last Name
Thank you!
Error - something went wrong!